Regarding the impact of abnormal DNA methylation on inflammation and endothelial dysfunction in atherosclerosis, key protective factors such as KLF2, KLF4, and CREG exhibit anti-atherosclerotic actions. This evidence concerns the gene KLF2 and atherosclerosis.